sellWeak cluster of 210b5-1 plan
Boxer Michael A sold $1.1M of TMO
SVP and General Counsel at THERMO FISHER SCIENTIFIC INC.. 2,000 shares at an average of $560.16, traded Oct 25, 2024, filed Oct 29, 2024.
Warning score
18Value
$1.1M
2,000 shares
Holdings after
12,736
-14% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001127602-24-026058, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 25, 2024 | MOption exercise Common Stock10b5-1 | +2,000 | $210.68 | $421k | 14,736 | Oct 29, 2024 |
| Oct 25, 2024 | SOpen-market sale Common Stock10b5-1 | -2,000 | $560.16 | $1.1M | 12,736 | Oct 29, 2024 |
| Oct 25, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,000 | $0.00 | $0 | 0 | Oct 29, 2024 |
Related signals
Other insiders at THERMO FISHER SCIENTIFIC INC. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 35Weak | sell10b5-1 | TMO THERMO FISHER SCIENTIFIC INC. | CASPER MARC N Chairman & CEO | $11M | 20,000 | |
| 48Moderate | sell 210b5-1 | TMO THERMO FISHER SCIENTIFIC INC. | CASPER MARC N Chairman & CEO | $5.0M | 9,000 | |
| 48Moderate | sell 210b5-1 | TMO THERMO FISHER SCIENTIFIC INC. | CASPER MARC N Chairman & CEO | $11M | 20,000 | |
| 23Weak | sell 210b5-1 | TMO THERMO FISHER SCIENTIFIC INC. | CASPER MARC N Chairman & CEO | $3.3M | 5,850 | |
| 28Weak | sell 210b5-1 | TMO THERMO FISHER SCIENTIFIC INC. | CASPER MARC N Chairman & CEO | $11M | 20,000 | |
| 28Weak | sell 210b5-1 | TMO THERMO FISHER SCIENTIFIC INC. | CASPER MARC N Chairman & CEO | $11M | 20,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.